Delivery Order SPE2DR25D6028-SPE2DR26FARRR
- Not listed
- The Defense Logistics Agency awarded a $17,257.88 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $34,598.52 to AmerisourceBergen Drug Corp for the supply of Enbrel Surclk 50mg in quantities of four units. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 29, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $16,622.35 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Enbrel 50 mg/ml syringes. This firm fixed-price, non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Enbrel 50 mg/ml syringes with a ceiling value of $23,242.77. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Enbrel 50 mg/ml syringes, with a ceiling value of $21,290.98. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under a larger indefinite delivery contract vehicle,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Enbrel Surclk 50mg in a quantity of four units, with a ceiling value of $62,380.74. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by September 10, 2025. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for ENBREL 50 mg/ml syringes valued at $29,284.84. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at the contractor's Conshohocken, Pennsylvania facility with...
- The Defense Logistics Agency awarded a $13,737.99 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL syringes, with an ultimate completion date of September 12, 2025. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and operates as a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,974.03 by the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. The delivery order, awarded under firm fixed-price terms with no set-aside designation, calls for the supply of Enbrel 50 mg/mL syringes. This award represents a child contract executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $57,377.95 delivery order to AmerisourceBergen Drug Corp for ENBREL Surclk 50mg 4s pharmaceutical products, effective October 28, 2025, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order is a child...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARRRDelivery Order
The Defense Logistics Agency awarded a $16,957.88 delivery order (contract number 4570004524) to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Enbrel Surclk 50mg in quantities of four units. This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 17, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. As a leading pharmaceutical prime vendor for the Defense Logistics Agency's medical supply chain, the company has demonstrated capability to meet federal procurement requirements through competitive bidding and delivers both brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to defense health customers, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 11/14/25 |